Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-08 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-06 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 4e-06 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |